| Financial Year |
March 31 2023 |
| Monetary Funds |
668,981,858.14 |
| Held-for-trading Financial Assets |
433,937,413.92 |
| Notes Receivable |
-- |
| Accounts Receivable |
36,885,016.82 |
| Advances to Suppliers |
161,667,144.94 |
| Other Receivables |
82,205,514.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
338,500.00 |
| Dividend Receivable |
-- |
| Inventories |
1,067,375,701.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
51,312,500.00 |
| Other Current Assets |
21,664,970.12 |
| Total Current Assets |
2,641,449,564.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,661,558,445.70 |
| Under-construction Projects |
104,099,750.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,219,657,559.36 |
| R&D expenses |
-- |
| Goodwill |
308,687,790.95 |
| Long-Term Deferred and Prepaid Expenses |
194,756,301.64 |
| Deferred Income Tax Assets |
47,821,951.72 |
| Other Non-Current Assets |
734,153,136.47 |
| Sub-Total of Non-Current Assets |
4,270,734,936.35 |
| Total Assets |
6,912,184,500.56 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
274,000,000.00 |
| Accounts Payable |
225,647,210.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,424,652.88 |
| Taxes Payable |
45,118,686.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
213,563,582.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
150,289,025.00 |
| Other Current Liabilities |
15,207,757.61 |
| Sub-Total of Current Liabilities |
1,128,625,659.96 |
| Long-term Loans |
50,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
53,339,137.19 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
196,861,621.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
344,424,907.89 |
| Total Liabilities |
1,473,050,567.85 |
| Paid-In Capital(Or Share Stock) |
853,555,763.00 |
| Capital Surplus |
2,076,745,690.84 |
| Surplus Reserve |
310,640,931.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,196,042,393.15 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,439,133,932.71 |
| Owner's Equity（Stockholder's Equity） |
5,439,133,932.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,912,184,500.56 |
